These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10933669)

  • 1. In vitro antibacterial activities of telithromycin, a new ketolide, against bacteria causing infections in obstetric and gynaecological patients.
    Mikamo H; Hua YX; Sato Y; Hayasaki Y; Tamaya T
    J Antimicrob Chemother; 2000 Aug; 46(2):332-4. PubMed ID: 10933669
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro and in vivo antibacterial activities of telithromycin.
    Mikamo H; Yin XH; Ninomiya M; Tamaya T
    Chemotherapy; 2003 May; 49(1-2):62-5. PubMed ID: 12714813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming antimicrobial resistance: profile of a new ketolide antibacterial, telithromycin.
    Leclercq R
    J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():9-23. PubMed ID: 11566972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
    Fernandes P; Pereira D; Watkins PB; Bertrand D
    J Med Chem; 2020 Jun; 63(12):6462-6473. PubMed ID: 31644280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distribution and antibiotic sensitivity of microorganisms in obstetric-gynecological infections].
    Katranushkova N; Tsankov Ts
    Akush Ginekol (Sofiia); 1973; 12(4):294-301. PubMed ID: 4767612
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae.
    Miyashita N; Fukano H; Niki Y; Matsushima T
    J Antimicrob Chemother; 2001 Sep; 48(3):403-5. PubMed ID: 11533006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of the new ketolide telithromycin (HMR 3647) in murine infection models.
    Bonnefoy A; Guitton M; Delachaume C; Le Priol P; Girard AM
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1688-92. PubMed ID: 11353612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of cefotaxime in the treatment of obstetric and gynaecological infections.
    Soutoul JH; Quentin R; Boscq G; Chazara C; Prieur D
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():283-5. PubMed ID: 6252172
    [No Abstract]   [Full Text] [Related]  

  • 9. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.
    Boswell FJ; Andrews JM; Ashby JP; Fogarty C; Brenwald NP; Wise R
    J Antimicrob Chemother; 1998 Dec; 42(6):703-9. PubMed ID: 10052892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens.
    Hammerschlag MR; Roblin PM; Bébéar CM
    J Antimicrob Chemother; 2001 Sep; 48 Suppl T1():25-31. PubMed ID: 11566973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ketolides: a critical review.
    Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
    Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of telithromycin against typical community-acquired respiratory pathogens.
    Buxbaum A; Forsthuber S; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 2003 Sep; 52(3):371-4. PubMed ID: 12888585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of telithromycin (HMR 3647) in relation to in vitro simulated human plasma kinetics.
    Bonnefoy A; Le Priol P
    J Antimicrob Chemother; 2001 Apr; 47(4):471-3. PubMed ID: 11266424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer.
    Alcaide F; Benítez MA; Carratalà J; Gudiol F; Liñares J; Martín R
    Antimicrob Agents Chemother; 2001 Feb; 45(2):624-6. PubMed ID: 11158768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue kinetics of telithromycin, the first ketolide antibacterial.
    Muller-Serieys C; Andrews J; Vacheron F; Cantalloube C
    J Antimicrob Chemother; 2004 Feb; 53(2):149-57. PubMed ID: 14729764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter study of the mechanisms of resistance and clonal relationships of Streptococcus agalactiae isolates resistant to macrolides, lincosamides, and ketolides in Spain.
    Gonzalez JJ; Andreu A;
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2525-7. PubMed ID: 15917563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telithromycin. Aventis Pharma.
    Johnson AP
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1691-701. PubMed ID: 11892930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of novel ketolides with 11,12-sulfur contained aryl alkyl side chains.
    Chen XZ; Xu P; Liu L; Zheng D; Lei PS
    Eur J Med Chem; 2011 Jan; 46(1):208-17. PubMed ID: 21130543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of the new ketolide telithromycin and other antibiotics against Streptococcus pneumoniae in Belgium.
    Verhaegen J; Verbist L
    Acta Clin Belg; 2001; 56(6):349-53. PubMed ID: 11881319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Macrolides and ketolides].
    Cobos-Trigueros N; Ateka O; Pitart C; Vila J
    Enferm Infecc Microbiol Clin; 2009; 27(7):412-8. PubMed ID: 19625112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.